Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2942
Selected: 0
NCT IDTitle
NCT00339144Study of Dasatinib (BMS-354825) in Patients With Solid Tumors
NCT03670667A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents
NCT04730544Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC.
NCT03642067Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
NCT00858871First Line Hepato Cellular Carcinoma (HCC)
NCT03325257Post-ATU Study of Nivolumab
NCT03190265Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer
NCT01017367Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)
NCT03402087A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
NCT04606316Surgical Nivolumab And Ipilimumab For Recurrent GBM
NCT00788333Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer
NCT01514864Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation
NCT03769558A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
NCT02541643Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
NCT00048932A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
NCT03336216A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
NCT04457284Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer
NCT03627806FLorida Puerto Rico Atrial Fibrillation Stroke Study (FLiPER-AF)
NCT02460978Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
NCT00645593Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
NCT01660906Phase IV, Open-label, Multicenter Study of Dasatinib in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients With Chronic, Low-grade Non-Hematologic Toxicity to Imatinib
NCT03563248Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
NCT06298643Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
NCT01656343Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
NCT00364793Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children
NCT0066645818-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
NCT04301414Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer
NCT05123950A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
NCT02161406A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
NCT02588625A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT07257120KarXT Concentrations in the Breast Milk and Plasma of Lactating Females
NCT03215927Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
NCT03267147PREVALENCE OF Anti-CCP POSITIVITY AND SUBCLINICAL SIGNS OF INFLAMMATION IN PATIENTS WITH NEW ONSET OF NON-SPECIFIC MUSCULOSKELETAL SYMPTOMS
NCT05284890A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants
NCT02475382Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen
NCT02378623Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli
NCT01489059Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma
NCT02991196Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer
NCT01156246Study to Assess the Effect of Food on Combination Dapagliflozin/Metformin Tablet in Healthy Volunteers
NCT07075406A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-Risk Myelodysplastic Syndromes Treated With Luspatercept
NCT00000625A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
NCT00226317Aripiprazole in the Treatment of Bipolar Depression
NCT07215962Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%
NCT03138499A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,
NCT03843658Identifying Novel Biomarkers in Early Rheumatology Patients
NCT02112110Absolute Bioavailability of BMS-791325
NCT00036608A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine
NCT01675076Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
NCT02514304Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding
NCT01396252Japanese Phase 1 Multiple Ascending Dose (MAD) Study